A study of Tregs in mammary carcinoma models demonstrated that tumor-infiltrating Tregs are a major source of receptor activator of nuclear factor-κB (RANK) ligand (RANKL), which stimulates tumor progression and lung metastasis from RANK-expressing mammary carcinoma cells [34]. This evidence concerns the gene TNFRSF11A and breast carcinoma.